For instance, an increased p-S6 expression in Tregs has been observed under inflammatory conditions, in tumor microenvironments, and during autoimmune disease progression, often coinciding with diminished FOXP3 expression and acquisition of effector-like properties (72). The gene discussed is FOXP3; the disease is autoimmune disease.